Michael Chang's Colleagues at ALX Oncology
Michael Chang's Contact Details
HQ
["(353) 161-8000"]
["(353) 161-8000"]
Location
Company
ALX Oncology
ALX Oncology
Michael Chang's Company Details
ALX Oncology is a publicly traded, clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridge the innate and adaptive immune system. ALX Oncology's lead product candidate, evorpacept (also known as ALX148), is a next generation CD47 blocking therapeutic that combines a high-affinity CD47 binding domain with an inactivated, proprietary Fc domain. Evorpacept has demonstrated promising clinical responses across a range of hematologic and solid malignancies in combination with a number of leading anti-cancer agents.
Frequently Asked Questions about Michael Chang
Michael Chang currently works for ALX Oncology.
Michael Chang's role at ALX Oncology is Vice President Operations.
Michael Chang's email address is ***@alxoncology.com. To view Michael Chang's full email address, please signup to ConnectPlex.
Michael Chang works in the Biotechnology industry.
Michael Chang's colleagues at ALX Oncology are Steffen P., Hank Stern, Andrew Olson, Abraham Fong, Michael Warner, Tim Welliver, Adela Hasa-Moreno and others.
Michael Chang's phone number is ["(353) 161-8000"]